Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine

Geng Chang Yeh, Pao Luh Tao, Julia Yi Ru Chen, Ming Cherng Lai, Fong Shui Gao, Chum Lin Hu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We had previously found that co-injection of dextromethorphan, an antitussive drug and a non-competitive NMDA receptor antagonist, with morphine into dam rats throughout the pregnancy period could attenuate the naloxone-precipitated morphine withdrawal syndrome in their offspring. In the present study, we further tested whether postnatal injection of dextromethorphan into the neonatal rats or a 3-day co-injection of dextromethorphan with morphine into the dam rats before delivery is also effective. Female Sprague-Dawley rats were bi-daily injected with escalating doses of morphine from a week before mating till the first postnatal week. Withdrawal syndrome of morphine in the offspring, manifested mainly as abdominal stretching, was generated by injection of naloxone on postnatal day 5. Direct injection of dextromethorphan into the offspring effectively reduced the severity of naloxone-precipitated abdominal stretching in a dose-dependent manner. A 3-day co-treatment with dextromethorphan given to the dam rat before delivery also had a similar attenuating effect, but the efficacy was lower than that produced by postnatal injection. Thus, the results from the present study support that dextromethorphan is of potential in treating or preventing neonatal morphine withdrawal syndrome.

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalEuropean Journal of Pharmacology
Volume453
Issue number2-3
DOIs
Publication statusPublished - Oct 25 2002

Fingerprint

Neonatal Abstinence Syndrome
Dextromethorphan
Morphine
Injections
Naloxone
Antitussive Agents
N-Methyl-D-Aspartate Receptors
Sprague Dawley Rats
Pregnancy

Keywords

  • Addiction
  • MK-801
  • Naloxone
  • NMDA receptor

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine. / Yeh, Geng Chang; Tao, Pao Luh; Chen, Julia Yi Ru; Lai, Ming Cherng; Gao, Fong Shui; Hu, Chum Lin.

In: European Journal of Pharmacology, Vol. 453, No. 2-3, 25.10.2002, p. 197-202.

Research output: Contribution to journalArticle

Yeh, Geng Chang ; Tao, Pao Luh ; Chen, Julia Yi Ru ; Lai, Ming Cherng ; Gao, Fong Shui ; Hu, Chum Lin. / Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine. In: European Journal of Pharmacology. 2002 ; Vol. 453, No. 2-3. pp. 197-202.
@article{9b14f55963ce41a08f501f5a9d75e3d9,
title = "Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine",
abstract = "We had previously found that co-injection of dextromethorphan, an antitussive drug and a non-competitive NMDA receptor antagonist, with morphine into dam rats throughout the pregnancy period could attenuate the naloxone-precipitated morphine withdrawal syndrome in their offspring. In the present study, we further tested whether postnatal injection of dextromethorphan into the neonatal rats or a 3-day co-injection of dextromethorphan with morphine into the dam rats before delivery is also effective. Female Sprague-Dawley rats were bi-daily injected with escalating doses of morphine from a week before mating till the first postnatal week. Withdrawal syndrome of morphine in the offspring, manifested mainly as abdominal stretching, was generated by injection of naloxone on postnatal day 5. Direct injection of dextromethorphan into the offspring effectively reduced the severity of naloxone-precipitated abdominal stretching in a dose-dependent manner. A 3-day co-treatment with dextromethorphan given to the dam rat before delivery also had a similar attenuating effect, but the efficacy was lower than that produced by postnatal injection. Thus, the results from the present study support that dextromethorphan is of potential in treating or preventing neonatal morphine withdrawal syndrome.",
keywords = "Addiction, MK-801, Naloxone, NMDA receptor",
author = "Yeh, {Geng Chang} and Tao, {Pao Luh} and Chen, {Julia Yi Ru} and Lai, {Ming Cherng} and Gao, {Fong Shui} and Hu, {Chum Lin}",
year = "2002",
month = "10",
day = "25",
doi = "10.1016/S0014-2999(02)02426-3",
language = "English",
volume = "453",
pages = "197--202",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine

AU - Yeh, Geng Chang

AU - Tao, Pao Luh

AU - Chen, Julia Yi Ru

AU - Lai, Ming Cherng

AU - Gao, Fong Shui

AU - Hu, Chum Lin

PY - 2002/10/25

Y1 - 2002/10/25

N2 - We had previously found that co-injection of dextromethorphan, an antitussive drug and a non-competitive NMDA receptor antagonist, with morphine into dam rats throughout the pregnancy period could attenuate the naloxone-precipitated morphine withdrawal syndrome in their offspring. In the present study, we further tested whether postnatal injection of dextromethorphan into the neonatal rats or a 3-day co-injection of dextromethorphan with morphine into the dam rats before delivery is also effective. Female Sprague-Dawley rats were bi-daily injected with escalating doses of morphine from a week before mating till the first postnatal week. Withdrawal syndrome of morphine in the offspring, manifested mainly as abdominal stretching, was generated by injection of naloxone on postnatal day 5. Direct injection of dextromethorphan into the offspring effectively reduced the severity of naloxone-precipitated abdominal stretching in a dose-dependent manner. A 3-day co-treatment with dextromethorphan given to the dam rat before delivery also had a similar attenuating effect, but the efficacy was lower than that produced by postnatal injection. Thus, the results from the present study support that dextromethorphan is of potential in treating or preventing neonatal morphine withdrawal syndrome.

AB - We had previously found that co-injection of dextromethorphan, an antitussive drug and a non-competitive NMDA receptor antagonist, with morphine into dam rats throughout the pregnancy period could attenuate the naloxone-precipitated morphine withdrawal syndrome in their offspring. In the present study, we further tested whether postnatal injection of dextromethorphan into the neonatal rats or a 3-day co-injection of dextromethorphan with morphine into the dam rats before delivery is also effective. Female Sprague-Dawley rats were bi-daily injected with escalating doses of morphine from a week before mating till the first postnatal week. Withdrawal syndrome of morphine in the offspring, manifested mainly as abdominal stretching, was generated by injection of naloxone on postnatal day 5. Direct injection of dextromethorphan into the offspring effectively reduced the severity of naloxone-precipitated abdominal stretching in a dose-dependent manner. A 3-day co-treatment with dextromethorphan given to the dam rat before delivery also had a similar attenuating effect, but the efficacy was lower than that produced by postnatal injection. Thus, the results from the present study support that dextromethorphan is of potential in treating or preventing neonatal morphine withdrawal syndrome.

KW - Addiction

KW - MK-801

KW - Naloxone

KW - NMDA receptor

UR - http://www.scopus.com/inward/record.url?scp=0037174813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037174813&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(02)02426-3

DO - 10.1016/S0014-2999(02)02426-3

M3 - Article

VL - 453

SP - 197

EP - 202

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -